Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QMF149 in Persistent Asthma
NCT00556673Phase 2Completed
- Sponsor
- Novartis
- Start
- Oct 2007
- Primary completion
- Apr 2008
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of indacaterol, mometasone in asthma, sponsored by Novartis. Started Oct 2007; status: completed.
02
Drugs
indacaterolmometasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00556673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00556673.